Trial Profile
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2022
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial occlusive disorders; Peripheral ischaemia
- Focus Therapeutic Use
- Acronyms Lutonix BTK Trial
- 03 Feb 2022 Status changed from active, no longer recruiting to completed.
- 07 May 2020 Planned End Date changed from 1 Jun 2020 to 1 Dec 2022.
- 07 Nov 2018 According to a VIVA Physicians media release, data from the study were presented at VIVA 18.